Social media

ICON is proud to be a sponsor at the upcoming #OCTNordics conference, taking place on 21–22 October in Copenhagen, Denmark. Join us at booth #41 to connect with our experts and explore how ICON is driving innovation and...

ICON is proud to be a sponsor at the upcoming #OCTNordics conference, taking place on 21–22 October in Copenhagen, Denmark. Join us at booth \#41 to connect with our experts and explore how ICON is driving innovation an...

On 28 October at 2:15 PM, ICON’s Suzanne Jansen, Head of QC Accelerated Pharmaceutical Solutions will present a session on Clinical innovation: Enabling dosing flexibility in early phase trials, an integrated CMC and man...

On 28 October at 2:15 PM, ICON’s Suzanne Jansen, Head of QC Accelerated Pharmaceutical Solutions will present a session on Clinical innovation: Enabling dosing flexibility in early phase trials, an integrated CMC and man...

Patient recruitment strategies need to evolve to ensure the best data from a wider range of patients. Meet ICON experts at #ESMO25, booth #3034 to learn how our strategic solutions and innovative methods help reduce pati...

Patient recruitment strategies need to evolve to ensure the best data from a wider range of patients. Meet ICON experts at #ESMO25, booth \#3034 to learn how our strategic solutions and innovative methods help reduce pat...

ICON is proud to be recognised as one of Marksmen Daily's ‘Most Preferred Workplaces for Women 2025-26’ in India. This distinction highlights our dedication to creating an environment where women feel valued, supported, ...

ICON is proud to be recognised as one of Marksmen Daily's ‘Most Preferred Workplaces for Women 2025-26’ in India. This distinction highlights our dedication to creating an environment where women feel valued, supported, ...

Discover the value of strategic early engagement during Stacey Flattery Vice President, General Partner, speaker session on Wednesday, 15 October at 11:30am at #OCTNewEngland2025. Learn how to optimize clinical outsourc...

Discover the value of strategic early engagement during Stacey Flattery Vice President, General Partner, speaker session on Wednesday, 15 October at 11:30am at #OCTNewEngland2025. Learn how to optimize clinical outsourc...

Women face delayed diagnoses, mischaracterized symptoms, and more years of poor health than men. But even when included in clinical trials, the tools used to measure outcomes often don’t reflect their lived experience. T...

Why do stability studies matter in early drug development? From shelf-life determination to regulatory readiness, a well-designed stability program ensures your drug product remains safe, effective, and reliable. Learn...